Toxicology – Drug Screening

Definition

Drug screening detects selected drugs or their metabolites in urine or blood.

In toxicology, drug screens are mainly an adjunct to the history, physical examination, vital signs, ECG, and targeted laboratory testing. They should not replace recognition of the patient’s clinical toxidrome.

The substances included in a drug screen vary considerably between laboratories.

Urine Drug Screening

Urine is commonly used because many drugs and their metabolites become concentrated in urine and remain detectable longer than in blood.

The major testing methods are:

• Immunoassay
• Chromatographic techniques
• Mass spectrometry for more definitive identification

Immunoassay

Mechanism

Antibodies recognize a particular drug or drug class. The resulting reaction is detected using an enzymatic or other laboratory method.

Advantages

• Rapid
• Relatively inexpensive
• Minimal specimen preparation
• Widely available

Limitations

• Detects only substances included in the assay
• Cross-reactivity can produce false-positive results
• Some members of a drug class may not be detected, producing false-negative results

For example, a routine opioid immunoassay may fail to detect certain synthetic or semisynthetic opioids unless specific assays are ordered.

Chromatography

Chromatographic methods separate substances according to their chemical properties.

Techniques include:

• Gas chromatography
• Liquid chromatography

These methods can identify a broader range of compounds than many routine immunoassays but generally require more specialized equipment and expertise.

Mass Spectrometry

Mass spectrometry is commonly combined with chromatography, such as:

• GC-MS: gas chromatography–mass spectrometry
• LC-MS/MS: liquid chromatography–tandem mass spectrometry

The technique identifies compounds based on characteristic molecular properties and provides much greater specificity than routine immunoassay screening.

It is particularly useful when definitive identification is required, although availability and turnaround time vary.

Targeted Serum Testing

For many important poisonings, a specific quantitative blood concentration is more useful than a broad urine drug screen.

Important examples include:

• Acetaminophen
• Salicylates
• Lithium
• Ethanol
• Methanol
• Ethylene glycol
• Selected anticonvulsants
• Theophylline

The appropriate test depends on the suspected exposure.

Clinical Uses

Routine broad toxicology screening is usually unnecessary in a patient whose history and clinical findings already establish the diagnosis.

Testing may be useful when:

• Altered mental status has no clear explanation.
• The reported ingestion does not match the clinical findings.
• Multiple or unknown substances may have been involved.
• Definitive identification would meaningfully change management.

The clinician should ideally know how the result will affect treatment before ordering the test.

Interpreting a Positive Result

A positive urine drug screen indicates that the assay detected a drug, metabolite, or cross-reacting substance.

It does not necessarily prove:

• Current intoxication
• The dose taken
• When the substance was used
• That the detected drug caused the patient’s current symptoms

Many substances remain detectable in urine after their clinical effects have resolved.

Interpreting a Negative Result

A negative drug screen does not exclude poisoning.

Possible explanations include:

• The drug is not included in the panel.
• The concentration is below the assay’s detection threshold.
• The specimen was collected too early.
• The urine is very dilute.
• The assay does not reliably detect that particular drug.
• The specimen was altered or substituted in nonclinical testing situations.

Therefore:

Negative screen ≠ no toxic exposure.

Important Limitations

Many clinically important toxicants are poorly assessed by routine urine drug screens and require specific testing or clinical diagnosis.

Examples include:

• Lithium
• Iron
• Heavy metals
• Toxic alcohols
• Cyanide
• Hydrocarbons

The exact limitations depend on the laboratory and assay being used.

Confirmatory Testing

When a screening result has major legal, occupational, forensic, or other consequences, an initial immunoassay result generally requires more specific confirmatory testing, commonly using mass-spectrometric techniques.

Key Points

• Treat the patient, not the drug screen.
• Urine immunoassays are convenient but have important false-positive and false-negative limitations.
• A positive urine result does not establish active intoxication.
• A negative result does not rule out poisoning.
• Targeted quantitative serum concentrations are more useful for several major toxicants.
• Always determine which substances the local laboratory panel actually detects.
• Drug screening is most valuable when the result can answer a specific clinical question or alter management.